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17824 | RSC Adv., 2017, 7, 17824–1783electron transfer promotes the
reduction of ferrylmyoglobin by uric acid under
physiological conditions†
Andressa de Zawadzki,ab Daniel R. Cardoso*a and Leif H. Skibsted*b
The hypervalent muscle pigment ferrylmyoglobin, MbFe(IV)]O, is not reduced by urate monoanions at
physiological conditions despite a strong driving force of around 30 kJ mol1 while for low pH, uric
acid was found to reduce protonated ferrylmyoglobin, MbFe(IV)]O,H+, eﬃciently in a bimolecular
reaction with k1 ¼ 1.1  0.1  103 L mol1 s1, DH‡ ¼ 66.1  0.1 kJ mol1 and DS‡ ¼ 35.2  0.2 J mol1
K1. For intermediate pH, like for anaerobic muscles and for meat, proton-coupled electron transfer
occurs in a transition state, {MbFe(IV)]O/H+/urate}‡, which is concluded to be formed from uric acid
and MbFe(IV)]O rather than from urate and MbFe(IV)]O,H+ with k3 ¼ 9.7  0.6  102 L mol1 s1, DH‡
¼ 59.2  0.1 kJ mol1 and DS‡ ¼ 11.5  0.3 J mol1 K1. The activation parameters as calculated from
the temperature dependence of the pH-reduction proﬁle in aqueous 0.067 mol L1 NaCl (from 25 C up
to 40 C), support a mechanism for reduction of hypervalent heme iron, where initial proton transfer to
oxo-iron initiates the intermolecular electron transfer from urate to ferrylmyoglobin. The concentration
of the powerful prooxidant ferrylmyoglobin increases strongly during digestion of red meat in the
stomach. A concomitant increase in uric acid concentration may serve as an inherent protection against
radical formation by ferrylmyoglobin.1. Introduction
Uric acid is the nal metabolite of purine bases in humans.1,2
Uric acid is an acid with a pKa1 value of 5.75 and a pKa2 of 9.8,
and in plasma is mainly present as the urate monoanion.1,3–5
Urate/uric acid is considered to be the major antioxidant in
human plasma, but the low aqueous solubility of both uric acid
and sodium urate carries a risk of precipitation of crystals of
uric acid or sodium urate in tissues and joints.1,2,6–8 Hyperuri-
cemia may lead to gout and other diseases and is oen related
to dietary habits and lifestyle.8–11
A high intake of red meat is frequently related to oxidative
stress and radical damage in the gastrointestinal tract leading
to pathological disorders.12–18 The oxidative damage seems to
arise from the formation of the hypervalent meat pigments
perferrylmyoglobin (cMbFe(IV)]O) and ferryl myoglobin
(MbFe(IV)]O).17,18 This activation of metmyoglobin (MbFe(III))
by H2O2 and/or organic hydroperoxides as present in
foods initiates a pseudoperoxidase catalytic cycle ofersidade de Sa˜o Paulo, Av. Trabalhador
-970, Sa˜o Carlos, SP, Brazil. E-mail:
of Copenhagen, Rolighedsvej 30, 1958
.ku.dk
tion (ESI) available. See DOI:
1myoglobin.12,13,17–19 Activation of MbFe(III) thus yields the very
short lived compound I (cMbFe(IV)]O) which subsequently
decays to the long-lived compound II (MbFe(IV)]O).20,21 Both
cMbFe(IV)]O and MbFe(IV)]O are strong oxidants known to
initiate lipid and protein oxidation in muscle tissues and in
meat products during storage and digestion.12,13,19 Knowledge of
the reaction kinetics and mechanisms by which toxic eﬀects of
hypervalent myoglobin species can be prevented or at least
diminished by diet components such as natural antioxidants,
are of relevance to improve human health through dietary
recommendations.17
Uric acid is generated in the gastrointestinal tract through
the breakdown of purine bases from the diet.2,3,7,22 Both serum
and gastrointestinal levels of uric acid may thus be modulated
by dietary factors and a high intake of red meat is traditionally
considered a risk factor for hyperuricemia and diseases result-
ing from this condition.7–10,23,24 A higher level of uric acid
formed in the digestive tract during food digestion could,
however, also have positive health eﬀects, since uric acid could
be important as a reductant of hypervalent meat pigments.25
The capability of uric acid and urate to deactivate hypervalent
myoglobin through the formation of iron(III) or iron(II) states in
eﬀect protecting the gastrointestinal tract and muscles against
radical damage has, however, not been studied.
In this view, aiming to contribute to a better knowledge of
the antioxidant role of uric acid and urate in biological system,
the reactivity of uric acid toward the hypervalent meat pigmentThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineferryl myoglobin under various pH and temperature conditions
was investigated by fast kinetic absorption spectroscopy.2. Materials and methods
2.1. Chemicals
Appropriate pH buﬀer solutions were prepared from K2HPO4/
KH2PO4 (J. T. Baker, Phillipsburg, NJ, USA) and from CH3-
COONa/CH3COOH (Sigma-Aldrich, Steinheim, Germany) with
deionized Milli-Q water (Merck Millipore Corporation, Darm-
stadt, Germany). Sodium chloride (Sigma-Aldrich) was used to
keep the ionic strength constant at 0.067 mol L1 for all pH
investigated. Ethylenediaminetetraacetic acid disodium salt
(EDTA), uric acid sodium salt, catalase from bovine liver and
metmyoglobin, MbFe(III), (from horse heart; purity > 90%), were
from Sigma-Aldrich (Steinheim, Germany). Catalase was used
without purication. Myoglobin was chromatographically
puried on a pD10 column (GE Healthcare Life Sciences, Chi-
cago, USA) and eluted with Milli-Q water, using 3525 nm ¼ 7700
M1 cm1 for spectrophotometric standardization of MbFe(III)
solution.26 Hydrogen peroxide (30% v/v) was obtained from
Sigma-Aldrich (Steinheim, Germany) and used without further
treatment. Ferrylmyoglobin was prepared from metmyoglobin
and hydrogen peroxide as previously described using catalase to
remove the excess of hydrogen peroxide.27 Uric acid stock
solutions were prepared in phosphate or acetate buﬀers and
were diluted in the suitable buﬀer to get a nal concentration of
2 103 mol L1. The nal pH and uric acid concentration were
adjusted by dilution to the required value for the kinetic
studies.2.2. Kinetic experiments
Optical absorption spectra were recorded at 25.0  0.1 C on
a Varian Cary 100 Bio UV-visible Spectrophotometer (Agilent
Technologies, Palo Alto, CA, USA) using quartz cuvettes of 1 cm
 1 cm (Hellma Analytics, Mu¨llheim, Germany).
The reduction of ferrylmyoglobin by uric acid was studied by
stopped ow absorption spectroscopy under pseudo-rst order
conditions with an excess of uric acid. Kinetic studies were
carried out in an Applied Photophysics SX20 sequential
stopped-ow system coupled to a photodiode array detector
(Applied Photophysics, Leatherhead, United Kingdom). Fresh
solutions of ferrylmyoglobin and buﬀered uric acid were placed
in two diﬀerent syringes of the equipment and a regular mixing
mode was used. The initial concentration was 15  106 mol
L1 MbFe(IV)]O, and for uric acid concentrations in the range
of 150–750  106 mol L1 were used. The pH-jump technique
was used as previously described in order to prevent protein
denaturation during a long exposure of MbFe(IV)]O to acidic
conditions.28,29 Absorption spectra were recorded from 200 to
800 nm at diﬀerent time intervals depending on the reaction
rate. Kinetic traces were taken from single wavelength to
calculate each observed rate constant by non-linear regression
for each set of conditions.
In order to investigate the inuence of temperature and pH
on the rate constant for the reduction of ferrylmyoglobin by uricThis journal is © The Royal Society of Chemistry 2017acid and urate, reactions were carried out at 25 C, 30 C, 35 C
and 40 C using buﬀered uric acid solutions with varying pH at
each temperature. All the solutions and the mixing chamber
were thermostated using a circulating water bath system. For
the pH range of 4.7–5.7, reactions were carried out in acetate
buﬀer, while at higher pH values, phosphate buﬀer was
preferred. Final pH of the mixture was measured at the end of
the reactions at the respective temperatures.2.3. Kinetic calculations
The OriginPro 2015 (OriginLab Corporation, Northampton, MA,
USA) soware package was used to process the experimental
datasets. Pseudo-rst order rate constants kobs were determined
by single exponential parameter tting. From the slope of the
linear t of kobs plotted against total uric acid concentration,
values for second-order rate constants were obtained for the
reactions at specic pH and temperature. From the pH-
dependence of the second-order rate constants, k0 specic rate
constants for the four possible reaction path identied were
derived using non-linear regression analysis, see Results and
discussion section.
The activation parameters were determined from the specic
rate constants at varying temperature through the use of the
Eyring equation:30,31
k0 ¼ kBT
h
 eDS
‡
R  eDH
‡
RT
where kB is the Boltzmann constant, h is Planck's constant and
R is the gas constant.
Plotting ln(k0/T) versus 1/T, where T is the temperature in
Kelvin and tting to an linear equation provided DH‡/R as the
slope and ln(kB/h) + DS
‡/R as intercept for each of the bimo-
lecular reaction.3. Results
Ferrylmyoglobin, MbFe(IV)]O, the hypervalent muscle
pigment, was not or only extremely slowly reduced by uric acid
at physiological conditions with neutral pH, where uric acid
with a pKa ¼ 5.75 is deprotonated to form the urate anion,
UA(NH)3
, despite a negative driving force of DG0 ¼ 29 kJ
mol1 for the reaction
MbFeðIVÞ]OþUAðNHÞ3 þ 2Hþ!
k4
MbFeðIIIÞOH2 þUAðNHÞ$3 (1)
as calculated from the reduction potential E0 ¼ +0.85 V for the
MbFe(IV)]O/MbFe(III) couple and E0 ¼ +0.59 V for the UA(NH)c3/
UA(NH)3
 couple at pH ¼ 7.3,32,33
For more acidic conditions the reduction of MbFe(IV)]O by
uric acid occurred with increasing rate for decreasing pH. For
all conditions investigated the initial reduction product met-
myoglobin, MbFe(III)OH2, was not reduced further to ferrous
myoglobin as was concluded from the UV-visible absorption
spectra, see Fig. 1, in agreement with a potential for the
MbFe(III)/MbFe(II) couple of E0 ¼ +0.05 V.34,35RSC Adv., 2017, 7, 17824–17831 | 17825
Fig. 1 Spectral changes for (A) Soret band and (B) Q bands indicating reduction of MbFe(IV)]O by uric acid. (C) Stopped-ﬂow kinetic traces at
405 nm (Soret band) for the reduction of ferryl myoglobin by uric acid and dependence of kobs on uric acid concentration at 25 C. Conditions: 5
 103 mol L1 acetate buﬀer pH 4.7 containing 1  103 mol L1 of EDTA; [MbFe(IV)]O]0 ¼ 15  106 mol L1. Second-order rate constants found
by linear regression was 775  109 L mol1 s1. (D) Stopped-ﬂow kinetic traces at 580 nm (Q band) for conditions as for (C). Second-order rate
constant found by linear regression was 791  133 L mol1 s1.
Scheme 1 Possible reaction pathways for ferrylmyoglobin species
reduction by uric acid/urate under diﬀerent hydrogenionic conditions.
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View Article OnlineThe reactivity of ferrylmyoglobin is known to be aﬀected by
pH.26,28,36 Protonation of ferrylmyoglobin (eqn (2)) and its
intermediates has been shown to occur under acidic conditions
to form highly reactive species that promptly oxidize relevant
biologic reductants.19,26,28
MbFeðIVÞ]OþHþ#MbFeðIVÞ]O;Hþ pKa ¼ 4:9 (2)
MbFeðIVÞ]O;Hþ#$þMbFeðIIIÞOH Kintra (3)
The increasing rate of reduction of MbFe(IV)]O at
decreasing pH has seen accounted for by protonation according
to the equilibrium of eqn (2) as is also increasing the rate of the
so-called autoreduction of MbFe(IV)]O assigned to specic acid
catalysis initiated through a intramolecular electron transfer to
form a protein radical cation as seen in eqn (3). However, the
increase in rate of reduction by urate at lower pH could also
result from a protonization of urate to form uric acid as another
reductant, and all four potential reactions of Scheme 1 need to
be considered.
Kinetic analysis for the reaction between the two acid/base
couples using time-dependent spectral measurements for the
reduction of ferrylmyoglobin to metmyoglobin is currently17826 | RSC Adv., 2017, 7, 17824–17831reported in literature based on the depletion in the absorbance
at 580 nm.27–29,37 In order to get reliable measurements from this
depletion it is necessary to use 30  106 mol L1 as
a minimum concentration of ferrylmyoglobin. However, the low
aqueous solubility of uric acid especially under acidic condi-
tions, requires the use of very low concentrations of ferrylmyo-
globin to ensure pseudo rst order conditions with an excess of
uric acid.38 Using an initial concentration of ferrylmyoglobin
below 15  106 mol L1, the absorbance at 580 nm is almost
close to the detection limit by standard visible spectroscopy.This journal is © The Royal Society of Chemistry 2017
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View Article OnlineThen, it became necessary to use a more sensitive wavelength
region to monitor the kinetics. The metmyoglobin Soret band
has higher extinction coeﬃcients (for example, 3405 nm ¼ 1.8 
104 L mol1 cm1) than the metmyoglobin Q bands and than
the Q bands of ferrylmyoglobin. The reduction of ferrylmyo-
globin was accordingly followed by the formation of MbFe(III)
OH2 monitoring the spectral changes in the Soret region
(390 nm to 430 nm). Fig. 1 shows the spectral changes for the
reduction of ferrylmyoglobin at 25.0  0.1 C and pH 4.7
monitored both at 405 nm and 580 nm. The observed pseudo
rst-order rate constants kobs were found to depend linearly on
the total uric acid concentration in agreement with a bimolec-
ular rate-determining step, see insert in Fig. 1C and D.
Consistent observations of isosbestic points, as may be seen in
Fig. 1, for all the conditions investigated, indicate that no
secondary reactions are occurring. The second-order rate
constants, k0, determined for the reduction of ferrylmyoglobin
using UV and visible wavelengths regions gave numerical values
for two diﬀerent spectral regions not diﬀering signicantly (r <
0.05). Then, for subsequent analysis, reactions were tracked by
measuring the increase in the absorbance of metmyoglobin at
405 nm. The second-order rate constants were obtained at pH
range of 4.7 to 7.5 at 25 C (Fig. 2) and the reduction showed
a pseudo rst-order kinetics behavior in this pH region of
physiological relevance for excess of urate/uric acid.
The four potential reactions according to the reactions of
Scheme 1 are
MbFeðIVÞ]O;Hþ þUAðNHÞ4!
k1
MbFeðIIIÞOH2 þUAðNHÞ$3
(4)
MbFeðIVÞ]O;Hþ þUAðNHÞ3 þHþ!
k2
MbFeðIIIÞOH2 þUAðNHÞ$3 (5)
MbFeðIVÞ]OþUAðNHÞ4 þHþ !
k3
MbFeðIIIÞOH2 þUAðNHÞ$3
(6)Fig. 2 Dependence of second-order rate constant, k0, on pH for the
reduction of ferrylmyoglobin by uric acid in aqueous 0.067 mol L1
NaCl at 25.0  0.1 C with full line calculated by non-linear regression
according to eqn (9).
This journal is © The Royal Society of Chemistry 2017MbFeðIVÞ]OþUAðNHÞ3 þ 2Hþ!
k4
MbFeðIIIÞOH2 þUAðNHÞ$3 (7)
On the basis of the possible four reactions between the acid/
base forms of the reactants, the second-order rate constant, k0,
as dependent on pH was used to estimate the specic rate
constants for these four reactions according to the following
rate expression for conditions of excess of uric acid/urate:28,31
d½MbFeðIVÞ]O
dt
¼ k0  ½MbFeðIVÞ]O  ½reductant
þ kMbFeðIVÞ]Oautoreduction (8)
in which,
k0 ¼ 1½Hþ þ KUAa
 ½Hþ þ KMbFeðIVÞ]O;Hþa


h
k1  ½Hþ2 þ

k3  KMbFeðIVÞ]O;Hþa þ k2  KUAa

½Hþ þ k4  KUAa  KMbFeðIVÞ]O;H
þ
a
i
(9)
and where KMbFeðIVÞ]O;H
þ
a is the acid dissociation constant of
MbFe(IV)]O,H+ and KUAa is the acid dissociation constant of uric
acid at 25 C. The kMbFe(IV)]Oautoreduction is known from previous studies
and makes a negligible contribution to the overall rate in the
actual pH-region.26
The rate constants for the two pathways, k1 and k4, were
accordingly estimated by nonlinear tting of k0 as function of
pH at 25 C together with the rate constant for the two reactions
of eqn (5) and (6) according to eqn (9). The reactions of eqn (5)
and (6) with the rate constants k2 and k3, respectively, notably
have a common transition state {MbFe(IV)]O/H+/urate}‡,
and due to the proton ambiguity the experimental rate constant
derived from eqn (9) can not be assigned to one of the two
reactions alone based on reaction kinetics.26,28 The non-linear
regression also included estimation of the pKa-value for uric
acid and the pKa-value for ferrylmyoglobin from the experi-
mental data, see Fig. 3 for the four temperatures. The estimated
numerical values for the two pKa values were in agreement with
the literature values.3,4,39,40 The distribution between acid/base
forms of the two reactants as a function of pH in agreement
with the determined pKa-values are shown in Fig. 4 for 25 C
together with the net charge on ferrylmyoglobin.
Based on a number of spectroscopic techniques, the pKa-
value of ferrylmyoglobin has been assigned to a value of pKa #
2.7, which is signicantly lower than the value obtained from
analysis of reaction kinetics.28,36 The two methods for esti-
mating the pKa-value may be related to two diﬀerent chemical
equilibria:
MbFeðIVÞ]O;Hþ#MbFeðIVÞ]OþHþ (10)
with pKspeca ¼ 2.7, and
$þMbFeðIIIÞOH#MbFeðIVÞ]OþHþ (11)RSC Adv., 2017, 7, 17824–17831 | 17827
Fig. 3 Temperature dependence of pH-proﬁle for second-order rate
constant, k0, for reduction of ferryl myoglobin by uric acid in aqueous
0.067 mol L1 NaCl at varying temperature.
Fig. 4 (A) Total protein charge ZH as function of pH for horse heart
myoglobin calculated with Protein Calculator v3.4 (http://
protcalc.sourceforge.net/cgi-bin/protcalc), sequences taken from
pdb ﬁles (P68082.2). (B) Acid/base equilibrium distribution of uric acid
and ferryl myoglobin as function of pH.
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View Article Onlinewith pKkina ¼ 4.9. The diﬀerence in the pKa-values is explained by
the intramolecular equilibrium of eqn (3) for which Kintra¼ Kkina /
Kspeca ¼ 160 now may be calculated.
The rate constant for the reduction of eqn (7) was not
signicantly diﬀerent from zero and the reaction of eqn (7) was
accordingly concluded not to make any contribution to the
reduction of ferrylmyoglobin. The reaction of eqn (4) on the
other hand had the value of 1.12  0.08  103 L mol1 s1 at
25 C, which makes this reaction very fast compared to the
autoreduction of ferrylmyoglobin which has a hydrogen ion
dependent second-order rate constant of 7.9  1.8  102 L
mol1 s1 at 25 C for pH 7 with 0.16 mol L1 of ionic strength.26
As for the reaction dominating for intermediate pH, the calcu-
lated constant for the reaction on eqn (5) and the calculated rate
constant for the reaction of eqn (6) can not be used to resolve
the reaction into the individual reactions, since these two
reactions has a common transition state.
The reduction of ferrylmyoglobin by uric acid was followed at
four temperatures in the same pH-region, see Fig. 3, and for
these four temperatures, the values for the specic rate constant
and pKa-values presented in Table 1 were obtained by non-
linear regression using eqn (9). The second-order rate
constants for each of the three reactions were analyzed
according to transition state theory as seen from the Eyring plot
of Fig. 5, not considering the reaction of eqn (7). The experi-
mental pKa-values showed little variation as demonstrated in
the temperature-region investigated, see Table 1. The activation
parameters calculated by linear regression from the three
independent plots of Fig. 5 may be found in Table 1.
The reaction between the protonated ferrylmyoglobin and
uric acid dominating at low pH has a relative large value for the
enthalpy of activation, which is larger than the value obtained
for reduction by ascorbate and by chlorogenate, as will be dis-
cussed below and, notably, is also larger than the value for
autoreduction. The activation is largely entropy-controlled for
the reduction by uric acid. Autoreduction seems to include an
initial intermolecular acid/base equilibrium involving a protein17828 | RSC Adv., 2017, 7, 17824–17831radical cation, see eqn (3), leading to reduction of iron(IV)-oxo to
iron(III) and to protein oxidation.
For uric acid reduction, proton coupled electron transfer
may be important for the formation of the radical cation form of
ferrylmyoglobin. Proton-coupled electron transfer seems even
more important for the reduction of ferrylmyoglobin at inter-
mediate pH. An initial proton-transfer to ferrylmyoglobin by
uric acid as depicted in Fig. 6 will lead to a protonated ferryl-
myoglobin for which electron transfer becomes facilitated. This
process involves proton transfer from uric acid followed by
electron transfer from urate and corresponds to the reaction of
eqn (6). However, a transition state with the same composition
arises from the reaction of eqn (5) for which, however, the
proton is transferred from protonated ferrylmyoglobin to urate
followed by electron transfer in the opposite direction. The
proton-coupled electron transfer, i.e. the reaction of eqn (6)
seems a more feasible reaction path and activation parameters
for this reaction will be used for comparison with reduction of
ferrylmyoglobin by other reactants. The important role of
a proton for electron transfer is evident, since the reaction
between the non-protonated ferrylmyoglobin and urateThis journal is © The Royal Society of Chemistry 2017
Table 1 Second-order rate constants, activation enthalpy and activation entropy for possible reaction path of importance for the reduction of
MbFe(IV)]Oby uric acid/urate in aqueous 0.067 MNaCl as calculated by non-linear regression at each temperature (see Fig. 3) together with pKa
values of protonated ferryl myoglobin and uric acid as estimated from the temperature dependence of the pH-reduction proﬁle
k0 (L mol1 s1)
DH‡ (kJ mol1) DS‡ (J mol1 K1)25 C 30 C 35 C 40 C
k1 1.12  0.08  103 2.10  0.05  103 2.91  0.12  103 4.80  0.10  103 66.1  0.1 35.2  0.2
k2 6.75  0.39  103 9.10  0.20  103 13.62  0.04  103 19.73  0.40  103 56.6  0.1 17.5  0.1
k3 9.76  0.56  102 1.56  0.03  103 2.61  0.16  103 3.35  0.07  103 59.2  0.1 11.5  0.2
pKa MbFe(IV)]O,H
+ 4.90  0.11 4.92  0.06 4.94  0.12 4.92  0.07
pKa UA(NH)4 5.74  0.24 5.70  0.14 5.66  0.25 5.69  0.16
Fig. 5 Eyring plots for reduction of ferrylmyoglobin by uric acid/urate
for each possible reaction path, see Scheme 1.
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View Article Onlinebecomes non-signicant and a limiting value for the rate
constant for eqn (6) may be calculated from eqn (9). A sug-
gested mechanism for the proton-coupled electron transfer is
shown in Fig. 6.
Deactivation of ferrylmyoglobin is important in muscles
during oxidative stress and decreasing pH as for anaerobic
metabolism. Uric acid seems to be important for such condi-
tions rather than for normal pH-conditions. Ascorbate has
a similar pH-prole and is also faster as a reductant at lower pH,
as may be seen from the comparison of rate constants andFig. 6 A possible mechanism for the proton coupled electron transfer f
This journal is © The Royal Society of Chemistry 2017activation parameters in Table 2. Hydrogen sulde (H2S) seems
to have a special role in deactivating hypervalent muscle
pigments, since cysteine as another sulfur based reductant, is
less eﬃcient than hydrogen sulde as reductant and even less
eﬃcient than oxygen-based reductants like ascorbate and
chlorogenic acid.27–29 Uric acid is a nitrogen-based reductant
and apparently the nitrogen based anion does not allow transfer
of an electron without the assistance of a proton, see Scheme 2.
Hydrogen atom transfer from uric acid is kinetically hampered
due to a strong hydrogen bonding pattern involving the
nitrogen–hydrogen bonds.41 However, the nitrogen hydrogen
are slightly acidic corresponding to a pKa ¼ 5.75 and may
initiate reduction through a proton transfer. Urate is as reduc-
tant diﬀerent from cysteine, as the anion of cysteine reduces
ferrylmyoglobin without the assistance of a proton in contrast
to urate.
Reduction of ferrylmyoglobin by various physiological rele-
vant reductants has a moderately high enthalpy of activation as
may be seen from Table 2, where oxygen and sulfur based
reductants are compared with uric acid/urate as a nitrogen-
based reductant. In general, protonization of MbFe(IV)]O to
yield MbFe(IV)]O,H+ accelerates the reduction due to entropy
eﬀects as are typically for outer-sphere electron transfer, which
has a positive value for entropy of activation. Such outer-sphere
electron transfer may occur for a protein radical cation, see eqn
(3). For the non-protonated MbFe(IV)]O, entropy of activation
is negative or close to zero, in eﬀect counteracting the moderate
enthalpy of activation suggesting an inner-sphere electron
transfer mechanism. This compensation eﬀect is especiallyrom uric acid to non-protonated ferrylmyoglobin.
RSC Adv., 2017, 7, 17824–17831 | 17829
Table 2 Rate constant and activation parameters for reduction of
ferrylmyoglobin and protonated ferrylmyoglobin in aqueous solution
by physiological relevant reductants at 25 C
k
(L mol1 s1)
DH‡
(kJ mol1)
DS‡
(J mol1 K1)
MbFe(IV)]O,H+ reduction by
Ascorbatea 1.7  103 62 24
Chlorogenatea 2.7  103 59 15
Uric acid 1.1  103 70 58
H2S
b 2.5  106
Cysteinec 5.1
Autoreductiond 7.9  102 59 3
MbFe(IV)]O reduction by
b-Lactoglobuline 2.4 45 93
Ascorbatea 2.9 51 63
Chlorogenatea 2.2  102 73 41
Uric acid 9.5  102 59 12
Urate 0
H2S
b 4.5  105
Cysteine thiolatec 3.1  101
Crocinf 1.8  102 55 17
Autoreductiond 1.6  104
a From Carlsen et al., 2000,27 determined in aqueous solution with ionic
strength 0.16 mol L1. b From Libardi et al., 2013,28 apparent values as
determined at pH 6.8. c From Libardi et al., 2014,29 apparent values as
determined at pH 6.8. d From Mikkelsen et al., 1995 (ref. 26). e From
Østdal et al., 1996;42 apparent values as determined at pH 7.0. f From
Jo´rgensen et al., 1997;43 apparent values as determined at pH 7.0.
RSC Advances Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
M
ar
ch
 2
01
7.
 D
ow
nl
oa
de
d 
on
 2
3/
03
/2
01
7 
12
:3
6:
15
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineevident for the sulfur-based reductants hydrogen sulde,
cysteine and b-lactoglobulin.42 For the oxygen-based reductant
ascorbate, a similar eﬀect is rather seen, when reduction of the
protonated MbFe(IV)]O,H+ is compared with the non-
protonated MbFe(IV)]O.27 The more negative entropy of acti-
vation for the reduction of the non-protonated MbFe(IV)]O by
the sulfur-based reductant or by ascorbate may reect the high
organization required in the transition state with a proton
partly transferred prior to electron transfer to the iron center of
ferrylmyoglobin. For the water-soluble carotenoid crocin,
a negative entropy of activation is likewise counteracting theScheme 2 Aqueous thermochemistry of uric acid used to identify the a
17830 | RSC Adv., 2017, 7, 17824–17831moderate enthalpy of activation and probably relates to direct
electron transfer from the conjugated double bond.43 A similar
eﬀect seems evident when reduction of MbFe(IV)]O,H+ and
MbFe(IV)]O by uric acid is compared. For the reduction of non-
protonated MbFe(IV)]O by uric acid, the initial proton transfer
entails high organization lowering the entropy of activation
from 35 J mol1 K1 to 12 J mol1 K1 when compared to
MbFe(IV)]O,H+. For urate as a possible reductant of non-
protonated MbFe(IV)]O, a further increase in activation
entropy makes this reaction of no importance kinetically when
compared to ferrylmyoglobin autoreduction.
Uric acid is accordingly considered to be the active reductant
for reaction at acidic conditions and for intermediate pH. For
intermediate pH, proton coupled electron transfer is equivalent
to donation of a hydrogen atom, as shown in Scheme 2, to
MbFe(IV)]O, where the oxidized uric acid is seen subsequently
to lose an additional proton from the uric acid neutral radical.
The urate ion is concluded not to be a reductant for
ferrylmyoglobin.
Sulfur is concluded to be a better electron donor for reduc-
tion of ferrylmyoglobin compared to oxygen as evident from
lower enthalpies of activation. Uric acid/urate as a N–H purine
base reductant is less eﬃcient and comparable to the carot-
enoid crocin as reductant. For uric acid/urate initial proton
transfer from N–H bond becomes of even more importance.
The prooxidative activity of hypervalent heme iron as formed
during digestion of red meat and meat products is getting
increasing attention as one possible explanation of the negative
health eﬀect of a high red meat intake.16–18 A balanced diet with
plant based antioxidants like polyphenols and carotenoids have
been found to protect against radical formation as the primary
oxidation step through eﬃcient reduction of perferrylmyoglo-
bin and ferrylmyoglobin under the acidic conditions of the
stomach. Endogenous factors in the form of metabolites like
carbon monoxide, hydrogen sulde and nitric oxide may,
however, may also be important for the protection against toxic
eﬀects of hypervalent iron. Uric acid may now be added to the
list of small molecules with protective eﬀect against radical
formation during digestion of meat and, in muscles, duringctual reactant for reduction of ferrylmyoglobin.
This journal is © The Royal Society of Chemistry 2017
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View Article Onlineoxidative stress. The level of uric acid depends on dietary
factors. However, an important observation seems to be that
urate despite its strong reducing capacity, only becomes active
against hypervalent heme iron through proton coupled electron
transfer as for the decreasing pH of muscles during anaerobic
conditions or under the acidic conditions of the stomach.Acknowledgements
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